Mice Model Market, By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice), By Service (Breeding, Cryopreservation, Model in-licensing, Genetic Testing), By Technology (CRISPR/CAS9, Embryonic Stem Cell Injection, Microinjection, Nuclear Transfer), By Application (Oncol

Mice Model Market Valuation – 2024-2031

Rising investments in research and development taking place in pharmaceutical projects, especially in oncology and personalized treatment, are driving up the demand for improved mouse models. Thus, growing demand for mice models from the pharmaceutical industry is estimated to help the market surpass the revenue of USD 1.63 Billion valued in 2023 to reach a valuation of USD 2.64 Billion over the forecast 2031.

Also, the need for accurate and efficient screening and testing of drug efficacy and safety before reaching the clinical phase of human trials enables the market to grow at a CAGR of 6.23% from 2024 to 2031.

Mice Model MarketDefinition/ Overview

A mice model is the use of mice (Mus musculus) in scientific research to replicate and investigate many aspects of human biology, physiology, and illness. These models are used because mice and humans have genetic, biochemical, and behavioral similarities, which provide useful insights into gene function, illness progression, and the evaluation of prospective therapies.

Furthermore, mice models serve an important role in biomedical research because they allow scientists to comprehend human diseases and test new treatments in a controlled setting. They are commonly used in cancer research, neurology, immunology, and genetics. Mice models assist researchers in understanding the intricacies of diseases, identifying genetic variables, and developing targeted medicines.

Will Increased Need for Mice Models in Biomedical Research Upsurge Sales of Mice Model?

The rising application of the mice model in the preclinical testing phase of drug discovery is expected to enhance the growth of the market in the coming years. Also,  increasing government support and investments in the development of the pharmaceutical industry is expected to create a completely upward scaling growth trajectory of the market.

The increased emphasis on customized treatment underlines the need for mice models that reflect individual genetic profiles and disease characteristics. Advanced mice models with humanized immune systems and particular mutations are fostering a high demand for successful tailoring treatment in the Mice Model Market.

Furthermore, the increasing need for compliance with stringent regulations during animal testing in some countries is a primary driver for the Mice Model Market. Mandatory preclinical testing in animals before the approval of new medications and therapies increases the demand for trustworthy and diverse mouse models for efficacy and safety studies developing the market.

Which are the Limitations Restraining the Use of Mice Models in Scientific Research?

The rising use of animal models for research and development is raising concerns regarding animal slaughtering and the risks of efficiency for further human application. This ethical issue associated with animal care is increasing public concern as well as insisting on revising the regulations. The demand for animal models in higher numbers is posing a challenge for the Mice Model Market.

The high costs and complications of breeding and maintaining high-quality mice models, particularly genetically engineered ones, act as a major barrier for the budget-constrained smaller research institutions and businesses. These hurdles increase with the necessary financial investment and specialized knowledge impacting the demand for the mice models.

Furthermore, the different regulatory environments practiced in diverse regions is likely to complicate and slow down project schedules, and also strict restrictions controlling animal research are raising costs. These inconsistencies among regions are projected to hamper the growth of the Mice Model Market.

Category-Wise Acumens

How will Rise in Adoption of CRISPR/CAS9 Technology Fare for Mice Model Market?

According to analysts, the CRISPR/CAS9 segment is estimated to hold the largest market share during the forecast period.  The advantageous properties including precision, efficiency, versatility, cost-effectiveness, and metamorphic nature offered by this solution is estimated to improve genetic research.

CRISPR/Cas9’s unmatched precision and efficiency in gene editing allow researchers to develop extremely specialized and adaptable mouse models, thereby transforming the area of genetic manipulation. The simplicity and adaptability of this technology resulted in its dominance, allowing scientists to target and change genes with unprecedented precision in the Mice Model Market.

Furthermore, the cost-effectiveness and ease of implementation of CRISPR/Cas9 when compared to traditional techniques is accelerating its widespread adoption. Thus, this technology is proving favorable in the case of producing genetically modified mice.

Why does Application in Field of Oncology Prove Resourceful for  Mice Model Market?

The oncology segment is estimated to dominate the Mice Model Market over the forecast period. Growing emphasis on complex cancer research activities is bolstering the use of genetically related mice models, especially guinea pigs, enabling mice models to gain momentum in the field of precision oncology.

Likewise,  the use of efficient animal models to investigate the complexities of oncogenesis and evaluate the prospective treatment strategies are projected to result in the expansion of the market. Because of their genetic resemblance to humans and their propensity for tumor formation, mice are useful models for studying many facets of cancer biology further resulting in the dominance of oncology application in the Mice Model Market.

Furthermore, the rise of personalized medicine techniques and the need for precision oncology solutions highlight the significance of using mice models that can closely mirror human responses to cancer treatments.

Gain Access into Mice Model Market Report Methodology

Country/Region-wise Acumens

Will Skyrocketing Demand for Personalized Medicine Prove Mercenary for North America?

According to analysts, North America is estimated to dominate the Mice Model Market during the forecast period owing to the continuous technological advancements and investments taking place the field of oncology and, personalized medicine.

The region’s ongoing efforts in oncology research are spurred by the high prevalence of cancer and significant government and corporate funding and initiatives dedicated to finding solutions. This causes an increased demand for advanced mise models in cancer research, propelling the growth in this region.

The growing demand for creating targeted medicines based on individual patients’ genetic profiles involves the use of sophisticated mice models that effectively represent human genetic variation. This is raising the need for more specialized and accurate mouse models for the development of patient-specific medical therapies in North America.

Furthermore, the significant presence of established regional firms, such as The Jackson Laboratory and Charles River Laboratories, leads to North America’s dominance in the Mice Model Market. These industry giants offer a comprehensive selection of high-quality mouse models and research services, increasing the region’s appeal to researchers and pharmaceutical companies.

How will the Mice Model Market Progress in Asia Pacific?

Asia Pacific is estimated to grow at the highest CAGR in the Mice Model Market during the forecast period. Growing inclination toward a sedentary lifestyle, dietary changes, and social habits such as smoking and drinking is resulting an increase in new or re-merging chronic diseases or infections such as tuberculosis and COVID-19. Thus, the need to analyze and develop new drugs or treatments to battle these diseases emphasizes on the application of mice models in research and therapeutic development in the region.  in the region.

Also, the flourishing pharmaceutical industry in the region to cater to the needs of the healthcare sector is a significant factor leading to the substantial growth of mice models in this market.

Furthermore, increased focus on heart and circulatory diseases, such as diabetes and cardiovascular disease, highlights the importance of comprehensive research tools, with mouse models playing an important role in elucidating disease pathways and facilitating the development of targeted interventions. The application of mice models in the healthcare sector drives the growth of the Mice Model Market in Asia Pacific.

Competitive Landscape

The Mice Model Market continues to grow, driven by an ever-increasing demand for innovative instruments in drug development and disease research.  The competitive landscape is highly dynamic, with ongoing innovation and collaboration determining the future of this critical sector.

Some of the prominent players operating in the Mice Model Market include

• The Jackson Laboratory
• Charles River Laboratories International, Inc.
• Envigo
• Taconic Biosciences
• Harlan Laboratories
• Janvier Labs
• Laboratory Animal Research Center
• Tokyo Laboratory Animals Co., Ltd.
• Biogen Laboratories
• Emmes
• Eurofins Scientific
• Syngenta
• Regeneron Pharmaceuticals, Inc.
• AbbVie Inc.
• Eli Lilly and Company
• Roche Holding AG
• Novartis AG
• Pfizer Inc.
• Merck & Co., Inc.
• Johnson & Johnson

Latest Developments

• In October 2023, Emmes, a drug discovery CRO, and Taconic Biosciences, a prominent provider of genetically modified mice, announced a collaboration to provide researchers with a broader selection of sophisticated mice models for preclinical studies. This alliance hopes to speed up medication development by giving researchers better tools to forecast therapeutic efficacy and safety.
• In October 2024, Charles River, a prominent provider of research models and services, expanded its gene editing capabilities through a collaboration with CRISPR Therapeutics. This will allow researchers to create personalized medicine models for more targeted and effective therapies.
• In October 2023, The Jackson Laboratory, a pioneer in mice genetics, announced a breakthrough in producing humanized mice models for cancer research. These models have a human immune system, which allows for more precise testing of cancer treatments and tailored medicine techniques.
• In September 2023, Regeneron, a leading biopharmaceutical company, and Janssen Pharmaceuticals announced a collaboration to create a novel mice model for investigating Alzheimer’s disease. This model will imitate important aspects of human disease, allowing for the development of new treatments.

Report Scope

Mice Model Market, By Category

Type

• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice
• Hybrid/Congenic Mice
• Other Services

Service

• Breeding
• Cryopreservation
• Model in-licensing
• Genetic Testing
• Other Services

Technology

• CRISPR/CAS9
• Embryonic Stem Cell Injection
• Microinjection
• Nuclear Transfer
• Other Technologies

Application

• Oncology
• Cardiovascular Studies
• Neurology
• Other Applications

End User

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.